These 3 Aussie stocks could skyrocket and stay there for decades

Let's see what sets these stocks apart from the rest.

| More on:
A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • CSL Ltd, a biotechnology leader with a robust plasma collection network and extensive R&D investment, offers high barriers to entry and future growth prospects despite recent share price pressure.
  • Pro Medicus, known for its Visage medical imaging platform, enjoys high margins and growth potential with sticky recurring revenues from long-term U.S. contracts, positioned to benefit from global healthcare digitization.
  • WiseTech Global, with its indispensable CargoWise platform in logistics, maintains a dominant market position with high switching costs and is poised for long-term growth through global trade expansion and strategic acquisitions.

Every now and then, the ASX delivers stocks with the potential not only to climb higher but to keep delivering for shareholders long after the initial run-up.

These are the kinds of businesses with strong competitive advantages, huge global markets, and management teams that know how to execute.

Let's now look at three Aussie stocks that tick these boxes and could be destined to skyrocket — and stay there for decades.

CSL Ltd (ASX: CSL)

CSL is a biotechnology giant that has turned into one of Australia's greatest corporate success stories. With its plasma therapies, vaccines, and specialty treatments, this Aussie stock has built a global footprint that few rivals can match.

What makes CSL so attractive for long-term investors is its moat. The company operates one of the world's largest plasma collection networks and reinvests heavily into research and development each year. This combination creates high barriers to entry and a pipeline of new treatments to fuel future growth.

While its share price has been under pressure recently, history suggests that CSL has the resilience and the innovation to keep compounding earnings well into the future.

Pro Medicus Ltd (ASX: PME)

Another Aussie stock to look at is Pro Medicus. It is a medical imaging software provider that's taking the healthcare world by storm. Its Visage platform allows hospitals and radiologists to view, share, and analyse images faster and more efficiently than traditional systems.

Once installed, Visage generates sticky recurring revenues from long-term contracts, particularly in the U.S. healthcare system. With major hospitals already on board and new deals being signed, Pro Medicus has plenty of room to grow.

Its margins are among the best on the ASX, and with the digitisation of healthcare accelerating globally, Pro Medicus could remain a top performer for decades.

WiseTech Global Ltd (ASX: WTC)

Finally, WiseTech Global has become an indispensable player in the logistics industry. The Aussie stock's CargoWise platform is used worldwide by freight forwarders, customs brokers, and transport companies to manage supply chains.

The company has carved out a dominant position by offering a single, integrated solution that replaces clunky, outdated systems. Its customer base is sticky, with high switching costs that make it difficult for rivals to compete.

With global trade volumes expected to keep rising and WiseTech expanding its product suite with acquisitions, its long-term growth potential is enormous. For investors, it could be a classic example of an ASX tech company with global scalability.

Motley Fool contributor James Mickleboro has positions in CSL, Pro Medicus, and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended CSL and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

woman talking on the phone and giving financial advice whilst analysing the stock market on the computer with a pen
Growth Shares

2 great ASX shares to buy for 2026: experts

These ASX shares are expected to deliver big returns in 2026…

Read more »

woman looking at iPhone whilst working on a laptop
Growth Shares

3 of the best Australian shares to buy and hold until 2035

It could be worth holding tightly to these shares for the long term.

Read more »

Two large bulls fight against each other in the dust.
Growth Shares

2 quality ASX 200 stocks to buy for your 2026 portfolio

Brokers are bullish on these mainstay sector picks.

Read more »

A woman stands at her desk looking a her phone with a panoramic view of the harbour bridge in the windows behind her with work colleagues in the background.
Growth Shares

Analysts say these ASX 200 shares could rise 30% to 40%

Big returns could be on offer with these growing stocks.

Read more »

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX 200 shares that could be top buys for growth

These two businesses have an exciting future.

Read more »

Man pointing at a blue rising share price graph.
Growth Shares

The 3 biggest ASX multibaggers in 2025

These billion-dollar ASX companies have delivered eye-catching multibagger returns in 2025.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Growth Shares

These world class ASX 200 growth shares could rise 40% to 80%

These high-quality shares are seriously undervalued according to brokers.

Read more »

A male ASX investor sits cross-legged with a laptop computer in his lap with a slightly crazed, happy, excited look on his face while next to him a graphic of a rocket shoots upwards with graphics of stars scattered around it
Healthcare Shares

Up 10x since July, could this hot ASX stock be the next Droneshield?

Investors chase asymmetric upside and 4DMedical is one of the ASX's hottest stocks right now.

Read more »